TIDMABC

RNS Number : 4817R

ABCAM Plc

29 June 2015

 
 For immediate release   29 June 2015

ABCAM PLC

("Abcam" or "the Company")

Appointment of Chief Legal Officer and Company Secretary

Cambridge UK: Abcam plc (AIM: ABC), a global leader in the supply of life science research tools, announces that it has appointed Suzanne Smith in the new role of Chief Legal Officer and Company Secretary, based at Abcam's headquarters in Cambridge, UK, effective from 6 July 2015. Accordingly, Jeff Iliffe will resign from the role of Company Secretary with effect from the same date.

Suzanne will take responsibility for Abcam's licensing, legal, compliance and company secretary activities. The new role has been created in order to help Abcam achieve its global growth objectives, supporting the Company's partnership and acquisition goals.

Suzanne brings a wealth of experience to Abcam with 20 years' global legal, business and leadership experience within the life science industry. She previously held the role of executive director, legal at Actavis plc, where she had responsibility for the leadership of the legal function internationally. Her prior roles include legal director at Genzyme Therapeutics Ltd, general counsel at Phoqus Pharmaceuticals plc and group legal counsel and company secretary at LGC Ltd. Suzanne is a qualified solicitor and holds an LLB law degree from the University of Exeter and an MBA from the Open University.

Alan Hirzel, CEO of Abcam, commented: "We are delighted to welcome Suzanne to Abcam's leadership team. Suzanne's knowledge and experience within the life sciences industry will be a valuable asset to our company."

For further information please contact:

 
                                                        + 44 (0) 1223 
Abcam                                                         696 000 
Jeff Iliffe, Chief Financial Officer 
 Laura Taylor, Investor Relations Manager 
 
J.P.Morgan Cazenove - Nominated Adviser & Joint      + 44 (0) 20 7742 
 Corporate Broker                                                4000 
James Mitford / Alex Bruce - Nominated Adviser 
 
                                                     + 44 (0) 20 7418 
Peel Hunt LLP - Joint Corporate Broker                           8900 
Clare Terlouw / Jock Maxwell MacDonald - Corporate 
 Broking

Notes to Editors

About Abcam

Abcam plc is a provider of life science research tools, with a wide range of products and expert technical support, enabling scientists to analyse living cells at the molecular level and improving the understanding of health and disease.

Abcam is committed to providing scientists with an extensive choice of reagents and tools, with the most comprehensive, honest and up-to-date datasheets and customer reviews, fast delivery and helpful customer service & technical support. The Company's catalogue evolves with scientific research trends and is growing each year to provide customers with products to meet their research needs. The range now includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam also supports its customers by hosting a range of global scientific events, forums and webinars, providing opportunities for scientists to get together and present their work.

Headquartered in Cambridge, UK, Abcam has nine global subsidiary offices enabling local services, multi-language support and next-day delivery in over 130 countries. The Company was founded in 1998, and now employs over 800 people. Abcam was admitted to AIM in 2005 (AIM:ABC).

To find out more, please visit www.abcam.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

COSSEESAUFISEEM

Abcam (LSE:ABC)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Abcam Charts.
Abcam (LSE:ABC)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Abcam Charts.